Cardinal Health, Inc. cash flow to debt ratio of 52.01% indicates that the company generates enough cash to cover its debts. This level indicates strong financial health.

Cardinal Health, Inc.'s free cash flow has increased 144.59% from $1.85B last year to $4.53B, signaling increasing performance

Cardinal Health, Inc.'s debt to equity ratio is -3.45, signaling that the company spent its equity and risk bankruptcy.

Cardinal Health, Inc.'s debt has increased relative to shareholder equity from -3.36 last year to -3.45 today, signaling weakened financials

Cardinal Health, Inc. has a net debt to EBITDA ratio of 1.46x, which is below the 3.00x threshold, indicating healthy leverage and financial stability

Cardinal Health, Inc.'s interest coverage ratio of 7.51 indicates that earnings with good margin can cover interest payments on company debt

Cardinal Health, Inc.'s profit margin was 0.70% last year and is 0.67% this year, signaling decreasing performance

Cardinal Health, Inc.'s short-term liabilities of $43.90B exceed its short-term assets of $38.75B, signaling financial risk

Cardinal Health, Inc.'s return on assets of 2.99% is lower than the 5.00% threshold, indicating inefficient asset utilization

Cardinal Health, Inc.'s return on equity of -59.73%, is lower than 15.00%, indicating bad performance

Cardinal Health, Inc.'s operating cash flow exceeds its net income, indicating high-quality earnings backed by actual cash generation

Cardinal Health, Inc. had positive net income in 4 out of 5 years, indicating stable and consistent earnings

Cardinal Health, Inc. has positive free cash flow, indicating the company generates cash after capital expenditures

Cardinal Health, Inc. has a free cash flow yield of 8.77%, which is above the 2.00% threshold, indicating strong cash generation relative to market value

Cardinal Health, Inc.'s yearly earnings has increased 9.80% since last year from $1.56B to $1.71B, signaling increasing performance

Cardinal Health, Inc.'s yearly revenue has increased 14.23% since last year from $222.58B to $254.25B, signaling increasing performance

ROIC 13.24% (Source: FMP key-metrics). At or above the 10% threshold. Score: 2 of 2. The company is generating returns above the upper end of the typical US weighted-average cost of capital range under this definition of invested capital.

Cardinal Health, Inc.'s 3-year revenue CAGR of 7.44% is positive, indicating growing revenue over the past 3 years

Cardinal Health, Inc. had revenue growth in 4 out of 5 years, indicating consistent revenue performance

Cardinal Health, Inc. had positive ROE in only 0 out of 5 years, indicating inconsistent returns on equity

Cardinal Health, Inc. is undervalued relative to its fair value price of 317.42 based on Base Cash Flow Valuation (DCF) model

Cardinal Health, Inc. has an earnings yield of 3.30%, which is below the 4.00% threshold, indicating the stock may be expensive relative to its earnings

Cardinal Health, Inc. is overvalued relative to its fair value price of 81.25 based on Base EBITDA Valuation model

Cardinal Health, Inc. has an EV/EBITDA ratio of 16.29x, which is below the 20.00x threshold, indicating reasonable valuation relative to its operating earnings

Cardinal Health, Inc. is overvalued relative to its fair value price of 107.03 based on Base Earnings Fair Value model

Cardinal Health, Inc. has a PEG-ratio over 1 which is considered overvalued

Cardinal Health, Inc. has negative shareholder equity; price-to-book is not meaningful and the check fails

Cardinal Health, Inc. has a price-to-sales ratio of 0.20x, which is below the 8.00x threshold, indicating reasonable valuation relative to its revenue